VCM
KNSA icon

Voleon Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Voleon Capital Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Sell
32,806
-87,579
-73% -$4.54M 0.04% 343
2026
Q1 		$5.8M Sell
120,385
-30,898
-20% -$1.37M 0.13% 178
2025
Q4 		$6.24M Buy
151,283
+62,117
+70% +$2.49M 0.13% 176
2025
Q3 		$3.46M Buy
+89,166
New +$2.9M 0.08% 237

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Voleon Capital Management's KNSA Position: Q2 2026 in Review

Voleon Capital Management reduced its Kiniksa Pharmaceuticals (KNSA) stake by 73% in Q2 2026, selling an estimated $4.54M and leaving 32,806 shares worth $2.1M. The position accounts for 0.04% of the portfolio, ranked #343.

Voleon Capital Management first reported a position in KNSA in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.24M in Q4 2025. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Voleon Capital Management held 32,806 shares of Kiniksa Pharmaceuticals worth $2.1M as of Q2 2026.
  • Voleon Capital Management sold 87,579 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $4.54M.
  • Kiniksa Pharmaceuticals made up 0.04% of Voleon Capital Management's portfolio in Q2 2026, its #343 holding.
  • Voleon Capital Management first reported a position in Kiniksa Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Voleon Capital Management's Kiniksa Pharmaceuticals position peaked at $6.24M in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.